Ishita Drugs & Industries standalone net profit declines 9.52% in the September 2024 quarter
Net profit of Ishita Drugs & Industries declined 9.52% to Rs 0.19 crore in the quarter ended September 2024 as against Rs 0.21 crore during the previous quarter ended September 2023. Sales declined 25.68% to Rs 3.27 crore in the quarter ended September 2024 as against Rs 4.40 crore during the previous quarter ended September 2023.
Particulars | Quarter Ended | ||
Sep. 2024 | Sep. 2023 | % Var. | |
Sales | 3.27 | 4.40 | -26 |
OPM % | 7.03 | 5.00 | - |
PBDT | 0.28 | 0.31 | -10 |
PBT | 0.25 | 0.28 | -11 |
NP | 0.19 | 0.21 | -10 |
Low Price Shares
0 mins read . Dec 18, 2024
Nifty 50 Top 10 Stocks
0 mins read . Dec 18, 2024
Best Stocks in 2025
0 mins read . Dec 18, 2024
Explore our products
₹0 Brokerage *
Open Demat Account